CDKN2B and infection: Previous studies have shown that recombinant TP antigens can enhance treponemal test performance, with IgG or IgM antibodies against TP15, TP17, and TP47 detectable 2–4 weeks after infection, earlier than non-treponemal antibodies (12, 44).